Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve-Sparing Radical Prostatectomy

Journal of Sexual Medicine

Volumn 9, Issue 2, 2012, Pages 608-617

  Briganti, Alberto ^a   di Trapani, Ettore ^a   Abdollah, Firas ^a   Gallina, Andrea ^a   Suardi, Nazareno ^a   Capitanio, Umberto ^a   Tutolo, Manuela ^a   Passoni, Niccolò ^a   Salonia, Andrea ^a   Digirolamo, Valerio ^a   Colombo, Renzo ^a   Guazzoni, Giorgio ^a   Rigatti, Patrizio ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Erectile dysfunction; Phosphodiesterase type 5 inhibitors; Radical prostatectomy; Rehabilitation

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR;

ADULT; AGE; AGED; ARTICLE; BILATERAL NERVE SPARING RADICAL PROSTATECTOMY; COMORBIDITY; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; ERECTILE DYSFUNCTION; HIGH RISK PATIENT; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PENIS ERECTION; PENIS REHABILITATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATECTOMY; RATING SCALE; REHABILITATION CARE; SCORING SYSTEM; TREATMENT DURATION;

EID: 84856513105     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02580.x     Document Type: Article

References (28)

1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F. EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61-71.
2. Gallina A, Chun FK, Suardi N, Eastham JA, Perrotte P, Graefen M, Hutterer G, Huland H, Klein EA, Reuther A, Montorsi F, Briganti A, Shariat SF, Roehrborn CG, de la Taille A, Salomon L, Karakiewicz PI. Comparison of stage migration patterns between Europe and the USA: An analysis of 11, 350 men treated with radical prostatectomy for prostate cancer. BJU Int 2008;101:1513-8.
3. Rabbani F, Stapleton AM, Kattan MW, Wheeler TM, Scardino PT. Factors predicting recovery of erections after radical prostatectomy. J Urol 2000;164:1929-34.
4. Ayyathurai R, Manoharan M, Nieder AM, Kava B, Soloway MS. Factors affecting erectile function after radical retropubic prostatectomy: Results from 1, 620 consecutive patients. BJU Int 2008;101:833-6.
5. Kundu SD, Roehl KA, Eggener SE, Antenor JA, Han M, Catalona WJ. Potency, continence and complications in 3, 477 consecutive radical retropubic prostatectomies. J Urol 2004;172:2227-31.
6. Eastham JA, Scardino PT, Kattan MW. Predicting an optimal outcome after radical prostatectomy: The trifecta nomogram. J Urol 2008;179:2207-10.
7. Descazeaud A, Debré B, Flam TA. Age difference between patient and partner is a predictive factor of potency rate following radical prostatectomy. J Urol 2006;176:2594-8.
8. Michl UH, Friedrich MG, Graefen M, Haese A, Heinzer H, Huland H. Prediction of postoperative sexual function after nerve sparing radical retropubic prostatectomy. J Urol 2006;176:227-31.
9. Dubbelman YD, Dohle GR, Schröder FH. Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol 2006;50:711-8.
10. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: A metaanalysis. J Sex Med 2009;6:2538-46.
11. Montorsi F, Brock G, Lee J, Shapiro J, Van Poppel H, Graefen M, Stief C. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 2008;54:924-31.
12. Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, Giuliano F, Brock G, Study Group. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 2008;20:479-86.
13. Bannowsky A, Schulze H, van der Horst C, Hautmann S, Jünemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: Improvement with nightly low-dose sildenafil. BJU Int 2008;101:1279-83.
14. Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, Rigatti P, Pizzini G, Miani A. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomised trial. J Urol 1997;158:1408-10.
15. Kovanecz I, Rambhatla A, Ferrini MG, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection. BJU Int 2008;101:203-10.
16. Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, Gonzalez-Cadavid N. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res 2008;20:202-12.
17. Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, Tal R, Li PS, Cohen-Gould L, Scardino PT. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med 2008;5:1126-36.
18. Briganti A, Gallina A, Suardi N, Capitanio U, Tutolo M, Bianchi M, Passoni N, Salonia A, Colombo R, Di Girolamo V, Guazzoni G, Rigatti P, Montorsi F. Predicting erectile function recovery after bilateral nerve sparing radical prostatectomy: A proposal of a novel preoperative risk stratification. J Sex Med 2010;7:2521-31.
19. Rosen RC, Cappelleri JC, Gendrano N 3rd. The International Index of Erectile Function (IIEF): A state-of-the-science review. Int J Impot Res 2002;14:226-44.
20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-83.
21. Physical status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995;854:1-452.
22. Walsh PC, Donker PJ. Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol 1982;128:492-7.
23. Montorsi F, Salonia A, Suardi N, Gallina A, Zanni G, Briganti A, Deho' F, Naspro R, Farina E, Rigatti P. Improving the preservation of the urethral sphincter and neurovascular bundles during open radical retropubic prostatectomy. Eur Urol 2005;48:938-45.
24. Novara G, Ficarra V, D'Elia C, Secco S, De Gobbi A, Cavalleri S, Artibani W. Preoperative criteria to select patients for bilateral nerve-sparing robotic-assisted radical prostatectomy. J Sex Med 2010;7:839-45.
25. Müller A, Parker M, Waters BW, Flanigan RC, Mulhall JP. Penile rehabilitation following radical prostatectomy: Predicting success. J Sex Med 2009;6:2806-12.
26. Mulhall JP, Parker M, Waters BW, Flanigan R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int 2010;105:37-41.
27. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008;5:476-84.
28. Mulhall JP, Bella AJ, Briganti A, McCullough A, Brock G. Erectile function rehabilitation in the radical prostatectomy patient. J Sex Med 2010;7:1687-98.